BioVie Announces First Patient Dosed in Phase 2a Clinical Trial
BioVie reported the dosing for the first patient in its phase 2a clinical trial of BIV201 for the treatment of refractory ascites due to liver cirrhosis.
BioVie (OTCQB:BIVI) reported the dosing for the first patient in its phase 2a clinical trial of BIV201 for the treatment of refractory ascites due to liver cirrhosis.
As quoted in the press release:
The initial trial will evaluate a total of 6 patients at the McGuire Research Institute in Richmond, VA.
“We are excited to start this study and dose the first patient with our Orphan drug candidate BIV201 (continuous low-dose infusion terlipressin)” said Patrick Yeramian MD, Medical Director for BioVie. “There is a clear need for an effective drug therapy for patients with refractory ascites, as there are no FDA-approved drugs for this condition. These patients frequently develop life-threatening complications due to their disease and suffer from a poor quality of life. Our clinical objective is to improve their health status and reduce the need for hospitalizations.”
Click here to read the full press release.
Source: www.marketwired.com
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1846.53 | +0.13 | |
Silver | 21.75 | +0.03 | |
Copper | 4.30 | +0.02 | |
Palladium | 1968.65 | +11.53 | |
Platinum | 957.67 | +3.19 | |
Oil | 110.35 | -1.86 | |
Heating Oil | 3.62 | -0.05 | |
Natural Gas | 8.06 | -0.25 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.